The eGFR Working Group focuses on improving the accuracy, consistency and equity of kidney function assessment across the UK. It considers the performance of eGFR equations based on creatinine, cystatin C or both, and how variation in testing and reporting can affect CKD identification, staging and prescribing.
Its work has included the AIM CKD UK study and a UKKA Patient Safety Alert on the lack of standardisation in kidney function measurement. The SIG is also considering how emerging evidence on cystatin C should inform access, implementation and national guidance.
Read the AIM CKD UK study
Read the eGFR Patient Safety Alert